Amlodipine Besylate and Benazepril Hydrochloride
- Product NDC
- 70934-637
- 11-digit product format
- 709340637
- Labeler code
- 70934
- Product ID
- 70934-637_ab0a460b-4abf-18f9-e053-2995a90a1fff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine Besylate and Benazepril Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA078466
- Marketing category
- ANDA
- Marketing start
- 2020-03-27
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-637-30 | 70934063730 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-637-30) | 30 capsule | 2020-03-27 | 0000-00-00 | No | No | Current |